Type
. Antileprosy activity and preliminary toxicological characteristics of some dialkyldithiocarbamate derivatives. Bulletin of experimental biology and medicine. 2008;145(4):446-8.
Type
. Genetic, epidemiological and biological analysis of interleukin-10 promoter single-nucleotide polymorphisms suggests a definitive role for -819C/T in leprosy susceptibility. Genes and immunity. 2009;10(2):174-80.
Type
. Development and validation of a severity scale for leprosy type 1 reactions. PLoS neglected tropical diseases [Internet]. 2008;2(12):e351. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2596969/pdf/pntd.0000351.pdf
Type
. Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. 2008;41(11):1005-10.
Type
. A randomized clinical trial of oral steroids for ulnar neuropathy in type 1 and type 2 leprosy reactions. Arquivos de neuro-psiquiatria. 2008;66(4):861-7.
Type
A day to remember leprosy. The Lancet. Infectious diseases [Internet]. 2009;9(1):1. Available from: http://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(08)70285-8.pdf
Type
. Constantine the Great and leprosy: fact or fiction?. Clinics in dermatology. 2009;27(1):139-41.
Type
. [Rheumatic manifestations in leprosy]. Acta reumatologica portuguesa [Internet]. 2008;33(4):407-14. Available from: http://www.spreumatologia.pt/sites/spreumatologia.pt/files/pdfs/ARP_2008_4_407_08__AR_-_Manifestacoes_reumaticas.pdf
Type
. Armadillos as a source of leprosy infection in the Southeast. Southern medical journal. 2009;102(1):113-4.
Type
Global leprosy situation, 2008 (additional information). Weekly epidemiological record [Internet]. 2008;83(50):459. Available from: http://www.who.int/wer/2008/wer8350.pdf